None
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. ASA grade I-II; 2. Age 18-65 years old; 3. Body mass index 18-30 kg/m^2; 4. Male and female patients requiring propofol-induced endotracheal intubation for general anesthesia.
Exclusion criteria
Exclusion criteria: 1. Refuse to participate in this study; 2. Unable to cooperate or communicate in Chinese; 3. Participate in other clinical studies; 4. Currently taking any painkillers; 5. Abuse of opioid drugs; 6. Suffering from diseases such as heart, brain, liver, and kidney disorders; 7. for laryngeal mask insertion due to full stomach, facial deformity, or difficulty in opening the mouth; 8. Hypertension, tachycardia, etc., with unstable hemodynamics.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Laryngeal mask airway insertion response score; | — |
Secondary
| Measure | Time frame |
|---|---|
| The highest values of MAP and HR and the lowest values of SPO2 were observed during the induction period after tegiladine injection;The incidence of hypertension, hypotension, bradycardia, tachycardia, and hypoxemia (SpO? < 90%) during the induction period after tegileridine injection.;The use of ephedrine and atropine during the induction period.;The requirement for additional propofol during the induction period.;The Ramsay Sedation Score of patients at 3 minutes after tegileridine injection.;Number of laryngeal mask airway insertion attempts;Conversion to general anesthesia with endotracheal intubation;Incidence of pain during propofol injection;Incidence of propofol injection pain;BIS latency, defined as the time interval from patient awakening to the decrease of BIS to 60 after tegileridine injection.;Incidence of adverse reactions (including coughing during induction, muscle rigidity, muscle tremors, limb movement, hiccups, allergic reactions, dizziness, etc.).;Patient baseline characteristics; | — |
Countries
China
Contacts
Lanzhou University Second Hospital